APA (7th ed.) Citation

Erblich, T., Manisty, C., Gribben, J., & Reikvam, H. (2024). Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk. Case Reports in Hematology, 2024, 1. https://doi.org/10.1155/2024/2312182

Chicago Style (17th ed.) Citation

Erblich, Thomas, Charlotte Manisty, John Gribben, and Håkon Reikvam. "Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk." Case Reports in Hematology 2024 (2024): 1. https://doi.org/10.1155/2024/2312182.

MLA (9th ed.) Citation

Erblich, Thomas, et al. "Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk." Case Reports in Hematology, vol. 2024, 2024, p. 1, https://doi.org/10.1155/2024/2312182.